what is in semaglutide that causes weight loss How Does Wegovy Work for Loss? GLP-1 Weight Loss Drugs: How

How long do you stay on Semaglutide for weight loss

Food and Drug Administration (FDA)-approved medications Mounjaro and Ozempic are currently facing lawsuits from patients who say that the combination of diabetes and weight loss drug left them with gastroparesis, more commonly known as stomach paralysis. The plaintiffs allege drug manufacturers didnt pre-warn patients about the problematic side effects

In October 2023, the FLOW trial was terminated early based on the recommendation of the independent Data Monitoring Committee (DMC), as Ozempic met the predefined efficacy criteria for early termination

Before its availability, patients who could benefit from GLP-1 receptor agonists were limited to injectable formats, which posed adherence challenges for some individuals